Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Evaluation of the Trial to Assess Chelation Therapy (TACT): the scientific process, peer review, and editorial scrutiny.

Bauchner H, Fontanarosa PB, Golub RM.

JAMA. 2013 Mar 27;309(12):1291-2. doi: 10.1001/jama.2013.2761. No abstract available.

PMID:
23532245
[PubMed - indexed for MEDLINE]
2.

Concerns about reliability in the Trial to Assess Chelation Therapy (TACT).

Nissen SE.

JAMA. 2013 Mar 27;309(12):1293-4. doi: 10.1001/jama.2013.2778. No abstract available.

PMID:
23532246
[PubMed - indexed for MEDLINE]
3.

Chelation therapy and cardiovascular outcomes.

Kleinman B.

JAMA. 2013 Jul 24;310(4):431. doi: 10.1001/jama.2013.7930. No abstract available.

PMID:
23917299
[PubMed - indexed for MEDLINE]
4.

Chelation therapy and cardiovascular outcomes.

Bittl JA.

JAMA. 2013 Jul 24;310(4):430-1. doi: 10.1001/jama.2013.7933. No abstract available.

PMID:
23917297
[PubMed - indexed for MEDLINE]
5.

Chelation therapy and cardiovascular outcomes--in reply.

Lamas GA, Mark D, Lee KL.

JAMA. 2013 Jul 24;310(4):431-2. doi: 10.1001/jama.2013.7954. No abstract available.

PMID:
23917300
[PubMed - indexed for MEDLINE]
6.

Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial.

Lamas GA, Goertz C, Boineau R, Mark DB, Rozema T, Nahin RL, Lindblad L, Lewis EF, Drisko J, Lee KL; TACT Investigators.

JAMA. 2013 Mar 27;309(12):1241-50. doi: 10.1001/jama.2013.2107.

PMID:
23532240
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

The effect of an EDTA-based chelation regimen on patients with diabetes mellitus and prior myocardial infarction in the Trial to Assess Chelation Therapy (TACT).

Escolar E, Lamas GA, Mark DB, Boineau R, Goertz C, Rosenberg Y, Nahin RL, Ouyang P, Rozema T, Magaziner A, Nahas R, Lewis EF, Lindblad L, Lee KL.

Circ Cardiovasc Qual Outcomes. 2014 Jan;7(1):15-24. doi: 10.1161/CIRCOUTCOMES.113.000663. Epub 2013 Nov 19.

PMID:
24254885
[PubMed - indexed for MEDLINE]
8.

Are concerns about reliability in the trial to assess chelation therapy fair grounds for a hasty dismissal?: An alternative perspective.

Kaul S.

Circ Cardiovasc Qual Outcomes. 2014 Jan;7(1):5-7. doi: 10.1161/CIRCOUTCOMES.113.000714. Epub 2014 Jan 14. No abstract available.

PMID:
24425709
[PubMed - indexed for MEDLINE]
9.

Design of the Trial to Assess Chelation Therapy (TACT).

Lamas GA, Goertz C, Boineau R, Mark DB, Rozema T, Nahin RL, Drisko JA, Lee KL.

Am Heart J. 2012 Jan;163(1):7-12. doi: 10.1016/j.ahj.2011.10.002.

PMID:
22172430
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Letter to the editor concerning article "Design of the Trial to Assess Chelation Therapy (TACT)".

Ernst E.

Am Heart J. 2012 Dec;164(6):e23; author reply e25. doi: 10.1016/j.ahj.2012.07.009. Epub 2012 Oct 31. No abstract available.

PMID:
23194497
[PubMed - indexed for MEDLINE]
11.

From the National Heart, Lung, and Blood Institute (NHLBI): EDTA chelation therapy modestly reduces cardiovascular events.

National Heart, Lung, and Blood Institute.

Ethn Dis. 2013 Summer;23(3):388. No abstract available.

PMID:
23914432
[PubMed - indexed for MEDLINE]
12.

Why the NIH Trial to Assess Chelation Therapy (TACT) should be abandoned.

Atwood KC, Woeckner E, Baratz RS, Sampson WI.

Medscape J Med. 2008 May 13;10(5):115.

PMID:
18596934
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Chelation therapy is TACT-less.

Jackson G.

Int J Clin Pract. 2008 Dec;62(12):1821-2. doi: 10.1111/j.1742-1241.2008.01946.x. No abstract available.

PMID:
19166425
[PubMed - indexed for MEDLINE]
14.

Clinical evaluation of chelation therapy: is there any wheat amidst the chaff?

Lamas GA, Ackermann A.

Am Heart J. 2000 Jul;140(1):4-5. No abstract available.

PMID:
10874253
[PubMed - indexed for MEDLINE]
15.

Percutaneous transmyocardial laser revascularisation.

Harbison J, Kenny RA.

Lancet. 2001 Feb 24;357(9256):638-9. No abstract available.

PMID:
11558518
[PubMed - indexed for MEDLINE]
16.

Chelation therapy for heart disease.

[No authors listed]

JAAPA. 2005 Jan;18(1):58. No abstract available.

PMID:
15675123
[PubMed - indexed for MEDLINE]
17.

Is ticlopidine more effective than aspirin in preventing adverse cardiovascular events after myocardial infarction (MI)?

Olson J, Huntington J.

J Fam Pract. 2001 Jul;50(7):623. No abstract available.

PMID:
11485713
[PubMed - indexed for MEDLINE]
18.

Chelation therapy for intermittent claudication-a reappraisal.

Godfrey ME, Chappell LT.

N Z Med J. 1996 Mar 8;109(1017):83. No abstract available.

PMID:
8606830
[PubMed - indexed for MEDLINE]
19.

Chelation therapy for heart disease.

Baeten SM.

JAAPA. 2005 Jan;18(1):57. No abstract available.

PMID:
15675122
[PubMed - indexed for MEDLINE]
20.

Chelation therapy ineffective as atherosclerosis treatment.

[No authors listed]

Mayo Clin Health Lett. 2002 Jun;20(6):4. No abstract available.

PMID:
12066805
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk